83 related articles for article (PubMed ID: 25457185)
1. Clear cell papillary renal cell carcinoma: a chromosomal microarray analysis of two cases using a novel Molecular Inversion Probe (MIP) technology.
Alexiev BA; Zou YS
Pathol Res Pract; 2014 Dec; 210(12):1049-53. PubMed ID: 25457185
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of FFPE based Wilms' Tumor samples through copy number and somatic mutation related Molecular Inversion Probe Based Array.
Singh N; Sahu DK; Goel M; Kant R; Gupta DK
Gene; 2015 Jul; 565(2):295-308. PubMed ID: 25913740
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
4. Unclassified renal cell carcinoma with tubulopapillary architecture, clear cell phenotype, and chromosome 8 monosomy: a new kid on the block.
Lan TT; Keller-Ramey J; Fitzpatrick C; Kadri S; Taxy JB; Segal JP; Furtado LV; Antic T
Virchows Arch; 2016 Jul; 469(1):81-91. PubMed ID: 27173781
[TBL] [Abstract][Full Text] [Related]
5. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.
Jones TD; Eble JN; Wang M; Maclennan GT; Jain S; Cheng L
Cancer; 2005 Sep; 104(6):1195-203. PubMed ID: 16047350
[TBL] [Abstract][Full Text] [Related]
6. Molecular inversion probes: a novel microarray technology and its application in cancer research.
Wang Y; Cottman M; Schiffman JD
Cancer Genet; 2012; 205(7-8):341-55. PubMed ID: 22867995
[TBL] [Abstract][Full Text] [Related]
7. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
[TBL] [Abstract][Full Text] [Related]
9. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
11. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
[TBL] [Abstract][Full Text] [Related]
13. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile.
Cifola I; Spinelli R; Beltrame L; Peano C; Fasoli E; Ferrero S; Bosari S; Signorini S; Rocco F; Perego R; Proserpio V; Raimondo F; Mocarelli P; Battaglia C
Mol Cancer; 2008 Jan; 7():6. PubMed ID: 18194544
[TBL] [Abstract][Full Text] [Related]
16. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
Minner S; Rump D; Tennstedt P; Simon R; Burandt E; Terracciano L; Moch H; Wilczak W; Bokemeyer C; Fisch M; Sauter G; Eichelberg C
Cancer; 2012 Mar; 118(5):1268-75. PubMed ID: 22161775
[TBL] [Abstract][Full Text] [Related]
18. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
Schraml P; Müller D; Bednar R; Gasser T; Sauter G; Mihatsch MJ; Moch H
J Pathol; 2000 Mar; 190(4):457-61. PubMed ID: 10699995
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma.
Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB
J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
